Lee Ainslie Guardant Health, Inc. Transaction History

Maverick Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $951,592 - $1.29 Million	-10,727 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $981,675 - $1.31 Million	9,939 Added 1261.29%	10,727 $1.34 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $86,498 - $130,555	788 New	788 $98,000
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $203,136 - $286,380	-1,599 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $159,836 - $217,352	1,599 New	1,599 $206,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.14B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.